Cargando…
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance
The influenza vaccine field has been constantly evolving to improve the speed, scalability, and flexibility of manufacturing, and to improve the breadth and longevity of the protective immune response across age groups, giving rise to an array of next generation vaccines in development. Among these,...
Autores principales: | Arunachalam, Arun B., Post, Penny, Rudin, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640007/ https://www.ncbi.nlm.nih.gov/pubmed/34857771 http://dx.doi.org/10.1038/s41541-021-00403-7 |
Ejemplares similares
-
An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines
por: Bodle, Jesse, et al.
Publicado: (2023) -
Evaluation of Haemagglutinin Content by RP-HPLC to Generate Pandemic Influenza Vaccine
por: Kang, Hyunkyung, et al.
Publicado: (2016) -
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection
por: Jawinski, Karina, et al.
Publicado: (2019) -
Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding
por: Lai, Jimmy Chun Cheong, et al.
Publicado: (2019) -
Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza
por: Ward, Melissa J, et al.
Publicado: (2013)